• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Eyebot Raises $20M to Scale 90-Second Vision Test and Doctor-Verified Prescriptions

by Syed Hamza Sohail 08/29/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Eyebot, the company behind the 90-second vision test kiosk that delivers doctor-verified glasses prescriptions, today announced it has raised $20 million in Series A funding. The round was led by General Catalyst, with participation from returning investors AlleyCorp, Baukunst, Village Global, and Ubiquity Ventures.

–  Eyebot is redefining how people access vision care by eliminating traditional barriers like appointment delays, insurance hurdles, and inaccessibility. Its kiosks—currently in malls, universities, retail stores, and grocery chains—provide a free, 90-second vision test that can also generate a glasses prescription reviewed and verified by licensed eye doctors.

Eyebot Secures New Funding to Redefine Vision Care Access Nationwide

Eyebot is transforming the way people access vision care with its 90-second, insurance-free vision test. Patients receive prescriptions quickly, affordably, and without the hassle of appointments—while every test is reviewed by a licensed eye doctor for accuracy and clinical oversight.

Following a successful pilot phase, Eyebot has already delivered over 45,000 free vision tests since its seed round last year and is on track to exceed half a million annually. With this new round of funding, the company will:

  • Expand across hundreds of new retail locations
  • Scale its clinical and engineering teams
  • Deepen engagement with eye care professionals

“Clear vision shouldn’t require months of waiting, high costs, or geographic luck,” said Matthias Hofmann, co-founder and CEO of Eyebot. “This funding allows us to accelerate our expansion, strengthen our clinical partnerships, and bring accessible vision care to millions more people.”

Eyebot is enhancing the in-person optical journey by making convenient, high-quality vision tests available in everyday settings such as malls, pharmacies, grocery stores, schools, and private practices. Several high-profile launches with leading retail partners are planned later this year to drive nationwide adoption.

Clinically-Sound, Doctor-Led Innovation

While Eyebot makes vision care more accessible, it is not replacing doctors—it is empowering them. Every prescription is reviewed by a licensed clinician, ensuring safety and quality. Eyebot has conducted more than 2,500 IRB-approved patient studies, demonstrating accuracy on par with traditional in-person exams. Its doctor-reviewed prescriptions consistently achieve higher satisfaction scores than the industry average.

To support its doctor-led approach, Eyebot has established a Clinical Advisory Board, chaired by Chief Medical Officer Dr. Alexander Martin, and composed of leaders from both optometry and ophthalmology. This board will guide the company’s clinical oversight as it scales nationwide.

Closing the Vision Care Gap

In the United States, more than 3 million people live with vision impairment, while 8 million more are affected by uncorrected refractive error such as nearsightedness. Millions delay or avoid care due to cost, long wait times, or lack of nearby providers.

Eyebot addresses this access gap by placing vision testing where people already are—enabling retailers to expand services with minimal footprint, supporting online eyewear brands entering physical storefronts, and helping established brick-and-mortar locations boost their capacity. The result is a new, scalable model for delivering affordable, doctor-supervised vision care nationwide.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |